Merck KGaA
Update in progressMRK.DE (XETRA)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Merck KGaA is a science and technology company with a global footprint. Its Life Science segment provides reagents, devices, software, and services for research, production, and testing across labs, biotech, pharma, and industry, plus bioprocessing tools and contract development services. The Healthcare segment develops and markets prescription drugs and biopharmaceuticals in oncology, neurology, fertility, cardiovascular, and metabolic areas. The Electronics segment supplies materials, chemicals, and equipment for semiconductor manufacturing. The company, founded in 1668, is headquartered in Darmstadt, Germany, and is a subsidiary of E. Merck KG. It has an in-licensing agreement with Abbisko Therapeutics for tenosynovial giant cell tumor drug candidates.
Company score
- Sentiment
- 1.34
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 1.68
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.73
- Governance
- 0.55
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.90
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 1.12
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!